|
|
NLARx News
Preventing Loss of Medicaid Drug Rebate Funds for States more
Special Report: States Must Act Now to Preserve Medicaid Drug
Rebates! more
|
Subscribe to the NLARx Blog and Join us on Facebook!
For up-to-the-minute posting of news of interest and events,
become a fan of NLARx on Facebook here and subscribe to our Blog.
|
News from the States
District of Columbia: Appeals Court finds DC PBM law violates ERISA Opinion Comments
Connecticut: Conn. AG Launches Probe Of CVS Prescription Plan Termination
Threat more
Florida: Prescription Drugs And Deaths In Florida more
Louisiana: Merck Wins First State Lawsuit Over Vioxx more
Michigan: University of Michigan Bans Industry Funded CME more
|
Outrage of the Week - Free Lunch for Doctors in Massachusetts??
Mass. Medical Device Leaders Hope for Repeal of Gift Ban's "Death by
1,000 Cuts" more
There Is Such a Thing as a Free Lunch, and Massachusetts Wants to Make
It Law more
What One Doctor And Staff Want For Lunch more
Lawmakers Propose Banning the Mass. Physician Gift Ban more
Ban on Drug Industry Gifts Could be Lifted more
Bill Would Kill Drug Industry Gift Ban more
|
|
Pharmaceutical Pricing
Group Purchasers, Devices And Innovation more
Vaccine Makers Accused Of Anticompetitive Pricing more
US And European Prices Aren't So Different After All more
Cutting Prices Thwarts Drug Development: Study more
Germany Moves Closer To Negotiated Pricing more
The Drug Industry: GlaxoSmithKline, Merck and Novartis Again Rank
Highest on Access to Poor more
U.S. Ranks Low Again On Health Care Quality, Efficiency And Equality,
Study Finds more
|
Conflict of Interest, CME, and Academic Detailing
ACCME: Peer Review, Plus Other Provider Controls, Enable Industry Employees to Headline CME Talks more
The AHA And ACCME Declare A Truce Over CME more
How Much Do Physicians Know About Their COI Policy? more
Latest Issue of Bioethics Journal Spotlights Ghostwriting more
Grassley Urges NIH To Focus On Ghostwriting more
|
Advertising and Marketing
Are Pharma Reps Salespeople or 'Robots'? more
Risky Business: How TV Drug Ads Should Talk About Risk more
Risky Business II: How Risk Should be Presented in TV Drug Ads more
One Pharma Company's Social Media Policy: Threaten Physicians Who
Complain About Your Drug Online more
DTC Spending Will Grow In 2010: Survey more
Free E-book: Social Media for Pharma more
Drug Groups to Limit Medicine 'Sampling' more
Most Docs Remain Positive About Pharma Marketing more
|
Pharma Watch
J&J Loses Bid To Dismiss Whistleblower Lawsuit more
The New Drugs don't Work for Big Pharma, Report Shows more
The Provenge Dilemma: Who Gets Dendreon's New Therapy? more
Grassley, Drugmakers And Whistleblower Protection more
Merck To Pay $8M In Damages In Fosamax Trial more
Should Pfizer Settle Prempro & Premarin Lawsuits? more
Doc Goes To Jail In Pfizer Research Fraud Case more
J&J Recall Plant to Stay Closed Through Year's End more
Johnson & Johnson Was A Repeat Offender more
After the Headlines, What Is the Real Avandia Story? more
Schering-Plough Shareholders Win A Round In Court more
Novo Nordisk, A Diabetes Med And Patient Chaos
more
|
PBM Watch
Decision PCMA v. District of Columbia, DC Court of Appeals more
Comments of Sharon Treat, Executive Director of the National Legislative Association on Prescription Drug Prices, on decision in PCMA v. District of Columbia more
CVS Caremark and Walgreens Announce New PBM Network Pharmacy
Agreement more
Medco Poised For Bright Future, Says Deutsche Bank more
Pharmacist: My Customers are Being Forced to go Elsewhere more
Wellpoint, Comparative Effectiveness And Boniva more
|
Patents and Generics
Editorial: Drug Company Payoffs more
House Proposal To End Pay-For Delay Generic Deals more
House Passes Patent Settlement Legislation as Part of the War Funding
Bill more
Patent Ownership And Federally Funded Research more
AstraZeneca Secures Deal with Academia more
AstraZeneca Wins A Crucial Crestor Patent Trial more
Mylan's Revenge: New Suit Threatens to Double Patent Defense Costs for
Big Pharma more
|
Medicare and Medicaid
Stand Alone Prescription Drug Plans (PDP) Penetration, 2010 more
Generic Drug Policies Could Save $100m Nationally, Study Says more
Second Round Of Checks To Close Medicare Doughnut Hole Sent
Out more
|
Safety and Clinical Trials
DA Prepares to Walk the Opiate REMS Line more
Doctors Want Pain Drugs To Be Tracked more
Avandia Decision a Bellwether for Obama FDA more
The Cholesterol Debate And Journal Disclosures more
Sara Carlin, Paxil And Drug Safety In Canada more
2 New Studies Add To Evidence Of Risks With Diabetes Drug Avandia As FDA
Prepares To Debate It's Safety more
|
NLARx Summer Meeting August 18th in Portland, Maine
We are meeting on the final day of the CSG Eastern Regional Conference (scheduled for August 15-18) in beautiful Portland Maine. Learn the latest on what states are doing to lower drug costs and implement federal health reform including changes to Medicaid rebates and the Sunshine Act. Registration and meeting details: more
|
|
|
|
|
|
|
Register now for our next meeting: